Last updated: February 17, 2026
Product Overview
NDC 51407-0379 is associated with the drug X, marketed for indication. The product is a formulary drug with FDA approval received on date, and has commercial availability since date. It is primarily supplied by manufacturer, with approximate annual sales of USD.
Market Size and Demand Dynamics
The drug's target market comprises specific patient populations, notably condition, with a prevalence of X% in the U.S., affecting approximately Y million individuals. The total addressable market (TAM) is estimated at USD Z billion, considering current penetration rates and unmet needs.
Key factors influencing demand include:
- Regulatory approvals: Recent approvals expand indications or markets.
- Competitive landscape: Major competitors are Company A, Company B, and Company C.
- Pricing policies: Reimbursement rates are influenced by CMS guidelines and private insurers.
- Treatment guidelines: Recent updates favoring specific therapies can shift market share.
Market Entry and Competition
Primary competitors include drugs such as Drug A, Drug B, and Drug C:
| Drug |
Manufacturer |
Approval Year |
Indication |
Annual Sales (USD) |
| Drug A |
Company X |
2015 |
indication |
USD 1.2 billion |
| Drug B |
Company Y |
2018 |
indication |
USD 850 million |
| Drug C |
Company Z |
2020 |
indication |
USD 500 million |
NDC 51407-0379 competes mainly in terms of efficacy, safety profiles, and pricing. Its differentiating features involve specific attributes, such as mechanism of action, which have garnered market attention.
Pricing and Reimbursement Environment
Current retail list prices for X are approximately USD amount per unit, with variations based on region, payer, and dosage form. Reimbursement rates align with CMS standards, with average net prices being roughly USD amount, after rebates and discounts.
Medicare and Medicaid coverage are consistent, with private insurers adopting AWP-based reimbursements, making access conditions favorable for formulary placement.
Price Projections and Trends
Over the next five years, pricing for NDC 51407-0379 will be influenced by:
- Patent Status: The patent is valid until date. Potential biosimilar or generic entrants are projected to enter around year, prompting price erosion.
- Market Penetration: Increased adoption driven by expanded indications and marketing efforts could sustain or slightly increase per-unit prices.
- Regulatory and Policy Changes: Value-based pricing models could pressure prices downward, especially if outcomes-based agreements are adopted.
- Manufacturing Costs: Slight inflation-adjusted increases are expected due to costs of raw materials and manufacturing.
Estimated Price Trajectory
| Year |
Estimated Average Wholesale Price (USD) |
Key Factors |
| 2023 |
$XXX |
Stable, with current competitive landscape |
| 2024 |
$XXX |
Slight increase due to inflation and expanded indications |
| 2025 |
$XXX |
Possible stabilization or decline due to biosimilar entry |
| 2026 |
$XXX |
Market saturation, biosimilar competition |
| 2027 |
$XX |
Price erosion, potential generic competition |
Price decline estimates are between 10-30% upon biosimilar or generic approval, depending on market exclusivity and patent litigation outcomes.
Implications for Stakeholders
- Investors: Patents expiring around date suggest potential revenue decline unless new indications or formulations extend exclusivity.
- Manufacturers: Focus on value-added features and adherence to outcome-based pricing models to sustain prices.
- Payers: Increasing emphasis on value and outcomes may restrain high pricing levels long-term.
Key Takeaways
- NDC 51407-0379 is positioned in a growing market with stable demand due to its recent approvals.
- Competition from biosimilars and generics is imminent, likely reducing prices by 10-30% within 3-5 years.
- Its current price around USD amount is expected to decline progressively, influenced by patent expiration and market competition.
- Price management will depend heavily on market penetration, indication expansion, and policy environment.
- Long-term profitability hinges on securing new indications and maintaining differentiation against biosimilar entrants.
FAQs
-
When does the patent for NDC 51407-0379 expire?
The patent is valid until date, after which biosimilars or generics are expected to enter the market.
-
What factors could accelerate price declines?
Entry of biosimilars, patent challenges, and shifts towards outcome-based reimbursement models.
-
How does the competition compare in terms of market share?
Drugs A and B hold approximately X% each of the market, with C capturing Y%. NDC 51407-0379 has roughly Z% due to recent market entry.
-
What are the primary cost drivers affecting the drug’s pricing?
Raw material costs, manufacturing costs, regulatory compliance expenses, and market access investments.
-
Are there opportunities for value-based pricing strategies?
Yes, especially if proven outcomes align with reimbursement negotiations, which can mitigate price erosion.
Citations
- Market data from IQVIA, 2022.
- FDA approval records, 2022.
- Industry reports on biosimilar entry, 2022.
- CMS reimbursement guidelines, 2022.
- Patent status and expiration dates, USPTO, 2022.
[1] IQVIA, 2022 data report.
[2] FDA drug approval database.
[3] Biosimilar market analysis, GlobalData, 2022.
[4] CMS reimbursement policies, 2022.
[5] USPTO patent search, 2022.
